
Sign up to save your podcasts
Or


An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
805805 ratings
An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
See omnystudio.com/listener for privacy information.

78,608 Listeners

32,175 Listeners

6,795 Listeners

29,046 Listeners

15,459 Listeners

2,690 Listeners

405 Listeners

2,178 Listeners

1,964 Listeners

420 Listeners

12,127 Listeners

17,808 Listeners

969 Listeners

112,586 Listeners

194 Listeners

30 Listeners

10,043 Listeners

4 Listeners

58 Listeners

233 Listeners

229 Listeners

65 Listeners

76 Listeners

82 Listeners

394 Listeners

18 Listeners

12 Listeners

7 Listeners

2 Listeners

72 Listeners

1,151 Listeners

186 Listeners